Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

LabCorp NIPT Performance Data

|Includes: Laboratory Corporation of America Holdings (LH)

LabCorp ($LH) informaSeq lab results

  • More than 90,000 samples reported in first year.
  • 136,633 samples from Aug-2014 to Feb-2016.
  • Demographic mix 56% high risk/44% ave risk.
  • 35% of tests ordered did not include clinical indication.
  • 1,866 screened positive for aneuploidy.

Pdf file can be found here


  1. The data references samples as opposed to patients, but the data in tables (i.e. Table 3) notes percentage of patients.
  2. The Ariosa preliminary S-1 noted 62% of their revenue was from LabCorp which suggests approximately 30,000 tests.
  3. informaSeq is a licensed product from Illumina ($ILMN). Initial validation demonstrated through concordance with Verifi as shown in the file.
  4. There was a substantial increase in the number of samples reported in the first year ended in Oct-2015 of 90,000 (average 7,500 per month) and the cumulative number of samples at the reporting cutoff date in Feb-2016 of 136,633. The 47,000 over about 4 months would mean an average monthly rate of about 12,000. Reasons could include OUS samples processed and unreimbursed samples to validate average risk.

Disclosure: I am/we are long ILMN.